{"id":1039160,"date":"2015-05-20T06:45:54","date_gmt":"2015-05-20T10:45:54","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/pharmacogenomics-american-medical-association.php"},"modified":"2024-08-17T16:24:39","modified_gmt":"2024-08-17T20:24:39","slug":"pharmacogenomics-american-medical-association","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/pharmacogenomics-american-medical-association.php","title":{"rendered":"Pharmacogenomics &#8211; American Medical Association"},"content":{"rendered":"<p><p>    What is pharmacogenomics?    Pharmacogenomics is the study of genetic variations that    influence individual response to drugs. Knowing whether a    patient carries any of these genetic variations can help    prescribers individualize drug therapy, decrease the chance for    adverse drug events, and increase the effectiveness of drugs.  <\/p>\n<p>    Pharmacogenomics combines traditional pharmaceutical sciences    such as biochemistry with with an understanding of common DNA    variations in the human genome. The most common variations in    the human genome are called single nucleotide polymorphisms    (SNPs). There is estimated to be approximately 11 million SNPs    in the human population, with an average of one every 1,300    base pairs. An individual's response to a drug is often    linked to these common DNA variations. In a similar manner,    susceptibility to certain diseases is also influenced by common    DNA variations. Currently, much of the research in the field of    pharmacogenomics is focused on genes encoding either metabolic    enzymes that can alter a drug's activity or defective    structural proteins that result in increased susceptibility to    disease.  <\/p>\n<p>    Anticipated benefits of pharmacogenomics    Pharmacogenomicshas the potential toprovide    tailored drug therapy based on genetically determined variation    in effectiveness and side effects. This will mean:  <\/p>\n<p>    Practical applications of pharmacogenomics    today    Following are links to scientific abstracts that discuss    practical applications of pharmacogenomics in cancer,    depression, cardiovascular disease and drug metabolism:  <\/p>\n<p>    Economic issues from molecule to    marketplace    Pharmacogenomics eventually can lead to an overall decrease in    the cost of health care because of decreases in:  <\/p>\n<p>    Additional resources  <\/p>\n<p>    The Department of Energy (DOE) Human Genome    Project Information - pharmacogenomics  <\/p>\n<p>    International HapMap Project  <\/p>\n<p>    National Institute of General Medical Science  <\/p>\n<p>    Listing of federally-sponsored clinical trials in    US  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Continued here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.ama-assn.org\/ama\/pub\/physician-resources\/medical-science\/genetics-molecular-medicine\/current-topics\/pharmacogenomics.page\" title=\"Pharmacogenomics - American Medical Association\" rel=\"noopener\">Pharmacogenomics - American Medical Association<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> What is pharmacogenomics? Pharmacogenomics is the study of genetic variations that influence individual response to drugs <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pharmacogenomics\/pharmacogenomics-american-medical-association.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246862],"tags":[],"class_list":["post-1039160","post","type-post","status-publish","format-standard","hentry","category-pharmacogenomics"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1039160"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1039160"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1039160\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1039160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1039160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1039160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}